Stock 600398 HLA GROUP CORP., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News Hla Group Corp., Ltd.

Equities

600398

CNE0000016H3

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
9.39 CNY +2.07% Intraday chart for Hla Group Corp., Ltd. +1.19% +26.55%
Apr. 11 Ose Immuno receives funding from Bpifrance CF
Mar. 19 HLA to Redeem Convertible Bonds Early MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Ose Immuno receives funding from Bpifrance
CF
HLA to Redeem Convertible Bonds Early
MT
Diamyd Medical Secures US FDA Fast Track Designation for Type 1 Diabetes Treatment
MT
OSE Immuno: collaboration agreement with GenDx
CF
Diamyd Medical Partners With DiaUnion for Diabetes Drug Trial
MT
Hla Group Corp., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Diamyd Medical Reports Updated Data on Subcutaneous Treatment to Delay Type 1 Diabetes Onset in Kids
MT
Immatics' IMA203 TCR-T Program Receives Regenerative Medicine Advanced Therapy Designation
MT
Diamyd Medical’s Diabetes Drug Shows Booster Safety in Mid-stage Study; Shares Jump
MT
IDEAYA Biosciences Initiates Phase 2 Expansion of Combination Therapy for Metastatic Cutaneous Melanoma
MT
Healthia Expands North American Laboratory Operations
MT
Hla Group Corp., Ltd.(XSSC:600398) added to S&P Global BMI Index
CI
Hla Group Corp., Ltd.(XSSC:600398) added to FTSE All-World Index
CI
OSE Immunotherapeutics' Lung Cancer Vaccine Extends Survival in Late-stage Study
MT
China Manufacturing Gloom Tempers Gains of Australian Equities
MT
Healthia Receives AU$260 Million Acquisition Bid from Pacific Equity Partners
MT
Hla Group Corp., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
CI
BriaCell Therapeutics Awarded National Cancer Institute Grant to Advance its Bria-OTS Immunotherapy for Cancer
MT
Marker Therapeutics Says Non-clinical Data Show MT-401 Inducing Anti-tumor Activity in Specific Setting
MT
OSE Immunotherapeutics Wins Cancer Vaccine Patent in US
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 600398 Stock
  4. News Hla Group Corp., Ltd.